PRISM BioLab Co.,LTD 206A.T
206A.T
PRISM BioLab Co.,LTD 4598.T
Delta-Fly Pharma, Inc. 4564.T
OncoTherapy Science, Inc. 4594.T
BrightPath Biotherapeutics Co., Ltd. 4576.T
D. Western Therapeutics Institute, Inc. 4883.T
Modalis Therapeutics Corporation 4891.T
TMS Co., Ltd. 4893.T
Noile-Immune Biotech Inc. 3750.T
ADR120S, Inc. 4582.T
SymBio Pharmaceuticals Limited
PRISM BioLab Co.,LTD 4598.T
Delta-Fly Pharma, Inc. 4564.T
OncoTherapy Science, Inc. 4594.T
BrightPath Biotherapeutics Co., Ltd. 4576.T
D. Western Therapeutics Institute, Inc. 4883.T
Modalis Therapeutics Corporation 4891.T
TMS Co., Ltd. 4893.T
Noile-Immune Biotech Inc. 3750.T
ADR120S, Inc. 4582.T
SymBio Pharmaceuticals Limited
Performance
| Periode | 206A.T | 4598.T | 4564.T | 4594.T | 4576.T | 4883.T | 4891.T | 4893.T | 3750.T | 4582.T |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -34.41 % | 1.21 % | -8.33 % | 77.78 % | -9.65 % | -2.56 % | -0.66 % | 15.22 % | 23.37 % | -18.59 % |
| YTD | -47.57 % | -9.71 % | -8.33 % | 45.45 % | -42.13 % | -30.28 % | -30.09 % | -12.64 % | -0.83 % | -36.82 % |
| 1Y | -54.75 % | -5.99 % | -35.29 % | 36.17 % | 47.14 % | -26.21 % | -16.57 % | -9.14 % | -2.11 % | -45.73 % |
| 3Y | -71.53 % | -16.61 % | -63.93 % | 3.23 % | -65.78 % | -78.89 % | -80.36 % | -77.76 % | -31.30 % | -82.06 % |
| 5Y | -71.53 % | -16.61 % | -85.99 % | -73.55 % | -71.39 % | -97.38 % | -80.36 % | -77.76 % | -43.30 % | -68.25 % |
| 10Y | -71.53 % | -16.61 % | -92.99 % | -84.62 % | -84.06 % | -96.59 % | -80.36 % | -77.76 % | 193.66 % | -85.76 % |
| From the beginning | -71.53 % | -16.61 % | -95.32 % | -84.62 % | -73.92 % | -96.59 % | -80.36 % | -77.76 % | -82.63 % | -91.42 % |